Bee Products and Traditional Plant Therapies for Wound Care: a comprehensive review of scientific evidence and clinical applications.|https://dx.doi.org/10.3831/KPI.2025.28.4.255
Proteolytic enzymes from Bacillus subtilis AB2 as antibiofilm adjuvants: Bioprocess optimization, mechanistic insights, and synergy with antibiotics.|https://dx.doi.org/10.71150/jm.2509019
Results of treating patients with diabetic foot ulcers with hyperbaric oxygen.|https://dx.doi.org/10.5603/imh.102276
A descriptive retrospective study on the various uses of hyperbaric oxygen therapy.|https://dx.doi.org/10.5603/imh.103441
Potential of phage therapy for the treatment of diabetic foot infections.|https://dx.doi.org/10.1007/s12223-025-01394-x
Prophylactic Incisional Negative Pressure wound therapy (NPWT) for major Amputations (PINTA): protocol for randomized controlled trial of single-use NPWT devices for closed-incision major lower extremity amputations.|https://dx.doi.org/10.1093/bjsopen/zraf159
Minimally Invasive Floating Metatarsal Osteotomy for Diabetic Foot Ulcers: A Systematic Review and Meta-Analysis.|https://dx.doi.org/10.1111/wrr.70123
Use of Polylactic Acid Dermal Matrix for the Management of Wounds with Exposed Avascular Structures.|https://dx.doi.org/10.3390/jcm15010003
Microbiological characteristics and risk factors for multidrug-resistant organism infections in diabetic foot ulcer.|https://dx.doi.org/10.12968/jowc.2023.0041
Rethinking regulatory tiers: Medicare real-world evidence shows CAMP outcomes are independent of FDA regulatory classification.|https://dx.doi.org/10.12968/jowc.2025.0609
Population structure, antimicrobial resistance, and virulence factors of diabetic foot-associated Escherichia coli.|https://dx.doi.org/10.1128/spectrum.02837-25
